SARS-CoV-2 Spike Protein and Pulmonary Arterial Hypertension: Implications for COVID-19 and Vaccines

被引：0
|
作者：
Suzuki, Yuichiro J. [1 ]
Sullivan, Robert D. [2 ]
Nikolaienko, Sofia I. [3 ]
Shults, Nataliia V. [1 ]
Gychka, Sergiy G. [3 ]
机构：
[1] Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC USA
[2] US Anesthesia Partners, Dallas, TX USA
[3] Bogomolets Natl Med Univ, Kyiv, Ukraine
来源：
AMERICAN JOURNAL OF PATHOLOGY | 2024年 / 194卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
SIP009
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [1] Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
    Jia, Zaixing
    Gong, Wenping
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (18)
  • [2] Comment on SARS-CoV-2 genome and spike protein, COVID-19, and efficacy of vaccines
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    CIRUGIA Y CIRUJANOS, 2025, 93 (01):
  • [3] Importance of the SARS-CoV-2 genome and spike protein in the immunopathogenesis of COVID-19 and the efficacy of vaccines
    Jimenez-Morales, Silvia
    Perez-Amado, Carlos J.
    Montufar-Robles, Isela
    Fragoso, Jose M.
    Aranda-Uribe, Ivan S.
    Ramos-Puga, David A.
    Martinez-Flores, Angel E.
    Ramirez-Bello, Julian
    CIRUGIA Y CIRUJANOS, 2023, 91 (02): : 268 - 276
  • [4] Pulmonary arterial hypertension post COVID-19: A sequala of SARS-CoV-2 infection?
    Khan, Abdul Wali
    Ullah, Irfan
    Khan, Kiran Shafiq
    Tahir, Muhammad Junaid
    Masyeni, Sri
    Harapan, Harapan
    RESPIRATORY MEDICINE CASE REPORTS, 2021, 33
  • [5] SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines
    Velusamy, Palaniyandi
    Kiruba, Kannan
    Su, Chia-Hung
    Arun, Viswanathan
    Anbu, Periasamy
    Gopinath, Subash C. B.
    Vaseeharan, Baskaralingam
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2021, 33 (08)
  • [6] SARS-CoV-2 Targets and COVID-19 Vaccines
    Currier, Arthur W.
    Jeshurin, Madeline C.
    Sampson, Valerie B.
    COVID, 2021, 1 (03): : 608 - 621
  • [7] SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
    Liang, Hong-Yu
    Wu, Yuyan
    Yau, Vicky
    Yin, Huan-Xin
    Lowe, Scott
    Bentley, Rachel
    Ahmed, Mubashir Ayaz
    Zhao, Wenjing
    Sun, Chenyu
    VACCINES, 2022, 10 (09)
  • [8] Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients
    George, Santosh
    Pal, Anasuya Chattopadhyay
    Gagnon, Jacqueline
    Timalsina, Sushma
    Singh, Pallavi
    Vydyam, Pratap
    Munshi, Muhammad
    Chiu, Joy E.
    Renard, Isaline
    Harden, Christina A.
    Ott, Isabel M.
    Watkins, Anne E.
    Vogels, Chantal B. F.
    Lu, Peiwen
    Tokuyama, Maria
    Venkataraman, Arvind
    Casanovas-Massana, Arnau
    Wyllie, Anne L.
    Rao, Veena
    Campbell, Melissa
    Farhadian, Shelli F.
    Grubaugh, Nathan D.
    Dela Cruz, Charles S.
    Ko, Albert, I
    Perez, Amalia Z. Berna
    Akaho, Elikplim H.
    Moledina, Dennis G.
    Testani, Jeffrey
    John, Audrey R.
    Ledizet, Michel
    Ben Mamoun, Choukri
    KIDNEY360, 2021, 2 (06): : 924 - 936
  • [9] COVID-19: Avoiding culture shock with the SARS-CoV-2 spike protein
    Hale, Benjamin G.
    ELIFE, 2021, 10
  • [10] SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines
    Suzuki, Yuichiro J.
    Gychka, Sergiy G.
    VACCINES, 2021, 9 (01) : 1 - 8
12345